3 Robust Sales Growth Stocks to Help You Thrive in a Risk-Averse Market

Market Overview: Navigating Uncertainty in 2024

The year began with challenges for U.S. markets, as shifting expectations around artificial intelligence and ongoing global tensions—particularly in the Middle East—sparked volatility and sector shifts. Concerns about inflation have further dampened investor confidence. Despite these headwinds, strong economic fundamentals and robust corporate earnings have helped limit losses and prevented a widespread retreat from riskier assets.

Why Sales Growth Is Key for Stock Selection

Traditional stock-picking methods remain valuable, especially in uncertain times. Focusing on sales growth offers a clearer picture of a company’s performance than earnings-based measures, which can be affected by accounting decisions or temporary cost changes. Companies such as Flowserve Corporation, Methanex Corporation, and Globe Life Inc. stand out as promising investments.

Consistent revenue growth signals genuine demand and often indicates expanding market share, a larger customer base, improved pricing power, or successful entry into new markets. Sustained top-line gains can also pave the way for future profitability, as increased sales volumes enhance operational efficiency and support long-term value creation for shareholders.

It’s important to assess revenue growth in context—comparing it to industry peers and considering the company’s position in the business cycle. The focus should be on quality growth, prioritizing steady demand over one-time boosts, aggressive discounting, or growth driven solely by acquisitions. Firms that achieve growth across various market conditions tend to generate stable cash flows, reinvest consistently, strengthen their financial position, and offer greater potential for expansion.

How to Identify High-Potential Stocks

To find stocks with strong sales momentum and substantial cash reserves, the screening process includes the following criteria:

• 5-Year Historical Sales Growth (%) above industry average
• Cash Flow exceeding $500 million

However, these factors alone are not enough. Additional metrics are considered to refine the selection:

• P/S Ratio below industry average: Indicates investors are paying less for each dollar of revenue, making the stock more attractive.
• % Change in F1 Sales Estimate Revisions (four weeks) above industry average: Positive estimate revisions often lead to stock price increases.
• Operating Margin (average over five years) above 5%: Reflects effective cost management and profitability from sales.
• Return on Equity (ROE) above 5%: Ensures that sales growth translates into profits, demonstrating efficient use of capital.
• Zacks Rank of 1 or 2: Stocks with these ranks are historically known to outperform, regardless of market conditions.

Three Stocks With Robust Sales Growth

• Flowserve Corporation (FLS): Based in Irving, Texas, Flowserve is a global leader in manufacturing and servicing advanced flow control systems. The company specializes in precision-engineered equipment for critical applications and offers a wide range of aftermarket services. Flowserve is projected to achieve a 6.3% sales growth rate in 2026 and currently holds a Zacks Rank #1.
• Methanex Corporation (MEOH): Headquartered in Vancouver, Methanex is the largest supplier of methanol worldwide, serving North America, Asia-Pacific, Europe, and Latin America. Its annual production capacity, including joint ventures, reaches 7.6 million tons. Methanex is expected to see a 9.8% sales growth rate in 2026 and has a Zacks Rank #2.
• Globe Life Inc. (GL): Based in McKinney, Texas, Globe Life is an insurance holding company offering individual life and supplemental health insurance through its subsidiaries. The company provides various nonparticipating life insurance products, including whole life and term life policies. Globe Life’s sales are forecasted to grow by 5.9% in 2026, with a current Zacks Rank #2.

Explore Zacks' Top Stock Picks

Since 2000, Zacks’ leading stock selection strategies have consistently outperformed the S&P’s annual average gain of 7.7%. Remarkably, these strategies have delivered average yearly returns of +48.4%, +50.2%, and +56.7%.

Access their latest recommendations at no cost or obligation:

For up-to-date stock picks from Zacks Investment Research, download the report featuring the 7 Best Stocks for the Next 30 Days.

Further Analysis Reports